Commodore Capital LP 13D and 13G filings for VistaGen Therapeutics, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2026-02-17 4:26 pm Purchase | 2025-12-31 | 13G | VISTAGEN THERAPEUTICS INC VTGN | Commodore Capital LP | 4,383,508 9.900% | 2,015,624 (+85.12%) | Filing |
| 2023-10-06 4:05 pm Purchase | 2023-10-04 | 13G | VISTAGEN THERAPEUTICS INC VTGN | Commodore Capital LP | 2,367,884 9.900% | 792,884 (+50.34%) | Filing |
| 2023-08-09 4:15 pm Purchase | 2023-08-07 | 13G | VISTAGEN THERAPEUTICS INC VTGN | Commodore Capital LP | 1,575,000 19.700% | 1,575,000 (New Position) | Filing |